Solventum rises after lifting annual profit forecast

Shares of medical device maker Solventum SOLV.N rise 1.8% to $73.24 premarket

Co late on Thursday raised its full-year adjusted profit forecast, driven by strong sales of its wound care and surgical sterilization products and lower expenses

Co now expects its 2025 adjusted profit per share to be in the range of $5.80 to $5.95, vs its previous estimate of $5.45 to $5.65 per share

Co reported Q2 adj.profit of $1.69 per share, higher than analysts' estimates of $1.44 per share, according to data compiled by LSEG

Sales in its MedSurg business, which provides wound dressings and surgical equipment, rose 4.8% to $1.22 billion in Q2

Up to last close, stock up 8.9% YTD